Johannes Schwenck

Hoppe Seyler Str. 3
Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Exploring extended [18F]FDG kinetics in lymphoma with ultra-late LAFOV-PET/CT.

Exploring extended [18F]FDG kinetics in lymphoma with ultra-late LAFOV-PET/CT.

Journal: European journal of nuclear medicine and molecular imaging

Published: October 04, 2025

Histologic Ex Vivo Validation of the [18F]SITATE Somatostatin Receptor PET Tracer.

Histologic Ex Vivo Validation of the [18F]SITATE Somatostatin Receptor PET Tracer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: January 31, 2025

CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients.

CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients.

Journal: Biomarker research

Published: February 08, 2024

Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies: Preliminary Evidence From a Clinical Pilot Study.

Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies: Preliminary Evidence From a Clinical Pilot Study.

Journal: Clinical nuclear medicine

Published: January 25, 2024

A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [64Cu]Cu-NOTA-ch14.18/CHO.

A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [64Cu]Cu-NOTA-ch14.18/CHO.

Journal: Theranostics

Published: November 22, 2023

Advances in PET imaging of cancer.

Advances in PET imaging of cancer.

Journal: Nature reviews. Cancer

Published: April 17, 2023

A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1.

A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1.

Journal: Cell metabolism

Published: April 15, 2023

Long-term prognostic factors for PRRT in neuroendocrine tumors.

Long-term prognostic factors for PRRT in neuroendocrine tumors.

Journal: Frontiers in medicine

Published: February 20, 2023

In vivo imaging of CD8+ T cells in metastatic cancer patients: first clinical experience with simultaneous [89Zr]Zr-Df-IAB22M2C PET/MRI.

In vivo imaging of CD8+ T cells in metastatic cancer patients: first clinical experience with simultaneous [89Zr]Zr-Df-IAB22M2C PET/MRI.

Journal: Theranostics

Published: October 18, 2022

Preclinical Identification Of Tumor-Draining Lymph Nodes Using a Multimodal Non-invasive In vivo Imaging Approach.

Preclinical Identification Of Tumor-Draining Lymph Nodes Using a Multimodal Non-invasive In vivo Imaging Approach.

Journal: Molecular imaging and biology

Published: September 22, 2022

First-in-Humans PET/MRI of In Vivo GD2 Expression in Osteosarcoma.

First-in-Humans PET/MRI of In Vivo GD2 Expression in Osteosarcoma.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: July 19, 2022

A role for artificial intelligence in molecular imaging of infection and inflammation.

A role for artificial intelligence in molecular imaging of infection and inflammation.

Journal: European journal of hybrid imaging

Published: February 07, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026